Skip to main content
SpringerLink
Log in

Albumin-human/recombinant-erythropoietin/sunitinib

Various toxicities and lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Zhou Q-Q, et al. Roxadustat for treatment of anemia in a cancer patient with endstage renal disease: A case report. World Journal of Clinical Cases 10: 6587-6594, No. 19, Jan 2022. Available from: URL: https://doi.org/10.12998/wjcc.v10.i19.6587

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Albumin-human/recombinant-erythropoietin/sunitinib. Reactions Weekly 1921, 18 (2022). https://doi.org/10.1007/s40278-022-22012-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-22012-2

Search

Navigation